Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA
Headache: The Journal of Head and Face Pain · 2023
DOI: 10.1111/head.14532 ↗At a glance
Journal article in Headache: The Journal of Head and Face Pain, 2023. Written by Francisco José Alberola-Amores and 1 co-authors. Institution: Headache Unit, Department of Neurology, Hospital General Universitario de Elche, Elche, Spain. Major MEDLINE topics: Botulinum Toxins, Type A, Headache Disorders. Cited 5 times so far (Crossref); 17 references.
Abstract (original language)
Epicrania fugax (EF) is a primary headache consisting of brief paroxysms of pain, lasting 1–10 s, that move through different nerve territories of one hemicranium with a linear or zigzag trajectory, although there are some clinical variants. Preventive therapy with anti‐seizure medication such as gabapentin and lamotrigine are most commonly used in patients presenting with frequent and non‐remitting attacks. In some cases, greater occipital nerve blockades are used for short‐ or long‐term relief. Here, we report two patients with a paroxysmal EF‐type pain who meet the criteria for EF of the International Classification of Headache Disorders, 3rd edition, with clear triggers and autonomic ocular signs and who failed multiple preventive treatments, but had a sustained response to onabotulinumtoxinA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Headache Unit, Department of Neurology, Hospital General Universitario de Elche, Elche, Spain.
ORCID profiles: Francisco José Alberola-Amores
Cite
APA
Alberola-Amores, F. J., & Moral-Rubio, J. (2023). Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14532
Vancouver
Alberola-Amores FJ, Moral-Rubio J. Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA. Headache: The Journal of Head and Face Pain. 2023. doi:10.1111/head.14532
BibTeX
@article{AlberolaAmores2023,
author = {Alberola-Amores, Francisco José and Moral-Rubio, Jorge},
title = {Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA},
journal = {Headache: The Journal of Head and Face Pain},
year = {2023},
doi = {10.1111/head.14532}
}
EUVIMED